简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-06-30 09:55 PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001
2025-06-27 14:52 IFF’s 2024 Do More Good Report Highlights Progress in Sustainability and Innovation
2025-06-27 10:44 Groups Representing Patients, Healthcare Professionals and Pharmaceutical Industry Author New Principle on Use of AI In Healthcare
2025-06-26 10:36 Parse Biosciences GigaLab to Support Mount Sinai Researchers in Generating One of the Largest Alzheimer's and Parkinson’s Single Cell Datasets
2025-06-25 13:48 Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin
2025-06-25 10:11 Amazfit Introduces Balance 2 Smartwatch and Helio Strap for Smarter Training, Better Recovery and Peak Performance
2025-06-24 10:05 IFF Opens New State-of-the-art Office in Hyderabad, India
2025-06-24 09:56 Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries
2025-06-24 09:45 Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges
2025-06-23 10:24 NEL Animal Cardiovascular Center Achieves World’s First Surgical Correction of Complex VSD in Canine Patient
2025-06-23 10:00 Prime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special Meeting
2025-06-23 09:51 SINOVAC Board of Directors Prevails Against Advantech/Prime’s New York Lawsuit
2025-06-19 11:13 LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials
2025-06-19 10:07 DNP to Take Controlling-Stake in Laxton
2025-06-18 16:42 SINOVAC Announces New Board Member
2025-06-18 16:15 ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years
2025-06-18 10:53 Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)
2025-06-16 17:36 HekaBio, Japan-based Biopharma and MedTech Platform, Enters Strategic Partnership with Alfresa Holdings Corporation
2025-06-16 10:54 Kao Releases the Kao Integrated Report 2025
2025-06-13 17:42 HOYA Vision Care Unveils Updates from the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting

Business Wire Weibo

Press Releases

Latest Releases